CellAegis Completes Patient Enrollment in Trial
CellAegis completed its patient enrollment in a large-scale, UK investigator-sponsored trial to further assess the efficacy of remote ischemic conditioning in reducing clinical events in patients presenting with STEMI in patients receiving treatment in hospital catheterization labs or emergency rooms.
Ontario Announces Trade Mission to RESI Boston, September 2018
Ontario's Ministry of International Trade, is organizing a Trade Mission to the RESI Conference, September 6, 2018, Boston Marriott Copley Place Hotel. This Trade Mission will be able to accommodate a maximum of ten Ontario companies.
How to Develop Commercialization Strategies and Be Ready for Anything: Reviewing Dr. Brian Jahns Keynote
During his lively and highly engaging presentation on June 12, ‘Strategic Marketing & Commercialization Plans for Early Stage Companies,’ Dr. Brian Jahns (Senior VP, Commercial and Business Development at Trillium Therapeutics Inc) discussed approaches for developing strategies and the importance of scenario planning.
OBIO's 'Use It or Lose It: Industry Solutions to Ontario's Commercialization Gap' Report Featured in Research Money
Executives from Ontario’s healthcare sector say they could benefit from a network of early adopter institutions and a capital fund that invests directly in health science companies preparing to commercialize their products and market them globally as they scale their businesses in Canada.
"Dream a Bigger Dream" Presentation by Scott Phillips, CEO, Starfish Medical
If you missed the Medical Device Playbook hosted by StarFish Medical and OBIO, you can still watch Starfish CEO Scott Phillips' presentation titled "Dream a Bigger Dream".
Radialis Medical Wins Pitch Competition
Radialis Medical won the Thunder Bay PITCH competition co-hosted by Northern Ontario Angels (NOA) and the Northern Ontario Innovation Centre (NOIC). Competitors' pitches were made to a panel of angel investors who voted on the best pitch.
Engaging the FDA: An Insider's Perspective
On June 14th, get behind-the-scenes on the recent changes at the FDA and learn more about how regulatory process changes affect your company.
Medical Device Playbook Recap and Photo Gallery
On May 10, 2018, Medical Device Playbook 2018 Toronto, co-hosted by Starfish Medical and OBIO, drew a standing-room only audience of 170 health science industry professionals, from company executives, to QA, regulatory and R&D engineering experts from start-ups, manufacturers, consultancies, regulatory and academic organizations.
OBIO 2018 Leadership Event Recap and Launch of ‘Use It or Lose It’ Report
On May 3, OBIO welcomed health science leaders, CEOs and the investment community to the tenth annual OBIO Leadership Event, also saw the launch of Use It or Lose It: Industry Solutions to Ontario's Commercialization Gap, OBIO's 2018 Industry Report.
OBIO Launches 'Use It or Lose It', Latest Report on the Future of Canada’s Health Science Industry
The Ontario Bioscience Innovation Organization (OBIO®) released its latest report, ‘Use It or Lose It: Industry Solutions to Ontario’s Commercialization Gap’, with recommendations from health science company executives on how to create the conditions for the growth of Ontario’s health science industry.
Proteocyte AI Announces Partnership With Proscia Digital
Proteocyte AI announced they have signed a partnership agreement to integrate Proscia’s technology with Straticyte™, a specific test for predicting the risk of progression to oral cancer.
OBIO CAAP Company Swift Medical Raises $11.6 Million in Oversubscribed Series A
Swift Medical, the world leader in enterprise-grade digital wound care management, has secured $11.6 million in funding
Register for Medical Device Playbook 2018, May 8th co-hosted by StarFish Medical and OBIO
Canada’s premiere innovation and commercialization event for medical device professionals, co-hosted by Starfish Medical and OBIO, Medical Device Playbook 2018 is coming to the MaRS Discovery District on May 8, 2018.
Applications Open for OBI ONtrepreneurs Program
Applications for the 2018 ONtrepreneurs Competition are now open. The Ontario Neurotech Entrepreneurs (ONtrepreneurs) Program catalyzes early stage entrepreneurs to commercialize brain-related technologies by accessing funding and support to launch or grow their neurotechnology ventures.
OBIO CAAP Company: Polumiros Wins 2018 FACIT Falcons' Fortunes competition
A panel of investor-judges has selected Ontario-based oncology researcher Soror Sharifpoor of Polumiros Inc. as the winner of the 2018 FACIT Falcons' Fortunes competition. The $50,000 award is intended to support further development of their innovative cancer research.
OBIO Pre-CAAP Company Adrenalease Launches KickStarter Campaign
Adrenalease announced the launch of a Kickstarter campaign to back their wearable posture apparel line. Once the campaign ends, the clothing is set to produce and ship to all backers by August 2018.
VBI Vaccines Announces Completion of Enrollment in PROTECT Phase 3 Clinical Study
VBI Vaccines announced the completion of enrollment with the last patient receiving the first dose in the ongoing PROTECT Phase 3 study of Sci-B-Vac®, the company’s third-generation hepatitis B vaccine.
OBIO CAAP Company CellAegis Announces First Patients Enrolled in U.S. SHIELD Pivotal Clinical Trial
CellAegis Devices announced enrollment of the first patients in a U.S. clinical trial of its autoRIC® device.
Impact Centre: Report on Physical Technologies Forum
The Impact Centre released a report on the Physical Technologies Forum, which summarized the ten big challenges Canada’s companies face when commercializing innovative physical technologies.
Ontario To Invest Up To $50M in Life Sciences Venture Capital Funds
Today, Ontario announced it will invest up to $50 million in venture capital funds focused on life sciences.
The Ontario Capital Growth Corporation (OCGC) has issued an expression of interest to identify fund managers to partner with other institutional investors such as corporations, banks and pension funds.